Nurse Practitioner, Family · Panorama City, CA
NPI
1376911131
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
8215 Van Nuys Blvd, Suite 210
Panorama City, CA, 91402
Phone (818) 901-0373
Groups this clinician bills Medicare through
Medicare paid, 2024
$835K
51,570 services
Medicare patients, 2024
615
Average age 74
Drug cost, 2024
$2.0M
12,240 prescriptions
Company payments, 2025
$81.12
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bernadette D Guia was code J0585 (injection, onabotulinumtoxina, 1 unit), 29,974 times for 157 patients. In total Bernadette D Guia billed 51,570 services in 56 codes, and Medicare paid $835K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 29,974 | 157 | $4.96 | $149K |
| 95004 Test - Miscellaneous | Office | 13,281 | 196 | $2.46 | $33K |
| 99213 Office E&M - Established | Office | 3,062 | 596 | $59.02 | $181K |
| 11056 Removal or Shaving of Skin Growth | Office | 607 | 164 | $60.99 | $37K |
| 11721 Nail Procedure | Office | 604 | 164 | $32.00 | $19K |
| 36415 Venipuncture Blood Collection | Office | 523 | 341 | $7.94 | $4,155 |
| 93925 Duplex Scan - Extremity Arteries | Office | 505 | 393 | $173.25 | $87K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 360 | 305 | $128.91 | $46K |
| 93306 Echocardiography (TTE/TEE) | Office | 321 | 269 | $133.91 | $43K |
| 93000 Electrocardiogram | Office | 281 | 238 | $9.25 | $2,598 |
| 99348 Home E&M - New and Established | Office | 257 | 122 | $45.49 | $12K |
| 95921 Electrical Nerve Conductivity | Office | 208 | 185 | $57.79 | $12K |
| 93970 Duplex Scan - Extremity Veins | Office | 206 | 154 | $114.94 | $24K |
| 64615 Musculoskeletal | Office | 201 | 154 | $99.63 | $20K |
| 17108 Destruction Skin Lesion | Office | 181 | 158 | $418.42 | $76K |
By year: 2022 $491K for 26,797 services; 2023 $561K for 34,642 services; 2024 $835K for 51,570 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 523 | 341 | $7.94 | $4,155 |
Medicare prescription drug claims, 2024
In 2024, the drug Bernadette D Guia prescribed most often to Medicare patients was Ibuprofen, with 424 prescriptions and refills. In total Bernadette D Guia wrote 12,240 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ibuprofen Generic | 424 | 442 | 63 | $2,339 |
| Atorvastatin Calcium Generic | 419 | 449 | 48 | $975 |
| Amlodipine Besylate Generic | 390 | 406 | 45 | $463 |
| Meclizine Hcl Generic | 336 | 343 | 38 | $1,751 |
| Tamsulosin Hcl Generic | 330 | 348 | 34 | $1,026 |
| Metoprolol Succinate Generic | 291 | 297 | 28 | $1,593 |
| Creon Lipase/Protease/Amylase | 268 | 303 | 49 | $141K |
| Metoprolol Tartrate Generic | 266 | 282 | 32 | $374 |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 261 | 294 | 41 | $365K |
| Rosuvastatin Calcium Generic | 250 | 274 | 28 | $604 |
| Gabapentin Generic | 247 | 251 | 26 | $566 |
| Levothyroxine Sodium Generic | 206 | 221 | 23 | $609 |
| Escitalopram Oxalate Generic | 200 | 211 | 23 | $502 |
| Omeprazole Generic | 190 | 198 | 22 | $484 |
| Donepezil Hcl Generic | 181 | 187 | 16 | $519 |
Brand drugs: 2,068 claims; generic drugs: 9,961 claims; opioid claims: 84.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bernadette D Guia $81.12 ($81.12 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $60.86.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.